Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.
Adult
Anti-HIV Agents
/ therapeutic use
Antitubercular Agents
/ therapeutic use
Brazil
Coinfection
/ immunology
Female
Flow Cytometry
Follow-Up Studies
HIV Infections
/ complications
Humans
Immune Reconstitution Inflammatory Syndrome
/ etiology
Immunity, Innate
Killer Cells, Natural
/ immunology
Male
Middle Aged
T-Lymphocyte Subsets
/ immunology
Treatment Outcome
Tuberculosis, Pulmonary
/ complications
IRIS
NK cell repertoire
TB/HIV Co-infection
clinical outcomes
innate immune cells
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
05
2019
accepted:
17
07
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
2
10
2020
Statut:
epublish
Résumé
Tuberculosis (TB) is the most common comorbidity and the leading cause of death among HIV-infected individuals. Although the combined antiretroviral therapy (cART) during TB treatment improves the survival of TB/HIV patients, the occurrence of immune reconstitution inflammatory syndrome (IRIS) in some patients poses clinical and scientific challenges. This work aimed to evaluate blood innate lymphocytes during therapeutic intervention for both diseases and their implications for the onset of IRIS. Natural killer (NK) cells, invariant NKT cells (iNKT), γδ T cell subsets, and
Identifiants
pubmed: 31456797
doi: 10.3389/fimmu.2019.01800
pmc: PMC6700218
doi:
Substances chimiques
Anti-HIV Agents
0
Antitubercular Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1800Références
Immunol Today. 2000 Nov;21(11):573-83
pubmed: 11094262
J Immunol. 2002 Apr 1;168(7):3451-7
pubmed: 11907104
AIDS. 2002 Jun 14;16(9):1251-6
pubmed: 12045490
Bull World Health Organ. 1992;70(4):515-26
pubmed: 1394786
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15011-6
pubmed: 14645713
J Immunol Methods. 2004 Nov;294(1-2):15-22
pubmed: 15604012
J Immunol. 2005 Oct 1;175(7):4611-7
pubmed: 16177106
Blood. 2006 May 1;107(9):3624-31
pubmed: 16384928
AIDS. 2006 Jan 9;20(2):F1-7
pubmed: 16511406
Clin Infect Dis. 2006 Jun 1;42(11):1639-46
pubmed: 16652323
Immunity. 2006 Aug;25(2):331-42
pubmed: 16901727
Tissue Antigens. 2006 Nov;68(5):386-9
pubmed: 17092251
AIDS. 2007 Apr 23;21(7):882-4
pubmed: 17415049
Immunology. 2007 Sep;122(1):1-14
pubmed: 17662044
Braz J Infect Dis. 2007 Oct;11(5):462-5
pubmed: 17962870
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):456-62
pubmed: 18077835
Clin Immunol. 2008 Apr;127(1):1-6
pubmed: 18304877
BMC Bioinformatics. 2008 Apr 29;9:221
pubmed: 18445269
Eur J Immunol. 2008 Jun;38(6):1756-66
pubmed: 18493987
Lancet Infect Dis. 2008 Aug;8(8):516-23
pubmed: 18652998
Am J Respir Crit Care Med. 2008 Nov 15;178(10):1083-9
pubmed: 18755923
Eur J Immunol. 2008 Nov;38(11):2934-7
pubmed: 18979511
Int Immunol. 2009 Jul;21(7):779-91
pubmed: 19461127
J Immunol. 2009 Sep 15;183(6):3915-23
pubmed: 19726768
J Interferon Cytokine Res. 2010 Jan;30(1):33-42
pubmed: 20028198
Curr Opin HIV AIDS. 2010 Jan;5(1):61-9
pubmed: 20046149
Iran J Immunol. 2010 Mar;7(1):1-7
pubmed: 20371914
AIDS Res Hum Retroviruses. 2010 Apr;26(4):459-69
pubmed: 20380481
Eur J Immunol. 2010 Aug;40(8):2174-81
pubmed: 20486123
Curr Opin Immunol. 1991 Feb;3(1):49-55
pubmed: 2054113
PLoS One. 2010 Jul 01;5(7):e11416
pubmed: 20617176
Tuberculosis (Edinb). 2010 Nov;90(6):361-6
pubmed: 20829117
Nat Rev Immunol. 2011 Feb;11(2):131-42
pubmed: 21267014
AIDS. 2011 Jul 31;25(12):1455-60
pubmed: 21610488
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):309-18
pubmed: 21826013
N Engl J Med. 2011 Oct 20;365(16):1471-81
pubmed: 22010913
Blood. 2012 Apr 5;119(14):3315-20
pubmed: 22343919
Clin Infect Dis. 2012 Jul;55(1):75-81
pubmed: 22423123
Antivir Ther. 2012;17(5):841-8
pubmed: 22543224
Clin Infect Dis. 2012 Oct;55(7):1004-11
pubmed: 22715179
Hum Immunol. 2013 Jan;74(1):85-92
pubmed: 23073291
PLoS One. 2013 Jun 19;8(6):e66095
pubmed: 23840403
Eur J Immunol. 2013 Aug;43(8):1995-2002
pubmed: 23928963
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):423-8
pubmed: 24226057
BMC Med. 2013 Dec 02;11:253
pubmed: 24295487
J Immunol. 2014 Jan 15;192(2):676-82
pubmed: 24337386
Science. 1989 May 12;244(4905):713-6
pubmed: 2524098
PLoS Pathog. 2014 Oct 02;10(10):e1004433
pubmed: 25275318
AIDS. 2015 Feb 20;29(4):421-31
pubmed: 25565499
Lancet Infect Dis. 2015 Apr;15(4):429-38
pubmed: 25672566
HIV AIDS (Auckl). 2015 Feb 12;7:49-64
pubmed: 25709503
PLoS One. 2015 Mar 26;10(3):e0121019
pubmed: 25811634
J Int Assoc Provid AIDS Care. 2015 Nov-Dec;14(6):560-70
pubmed: 26289343
Nat Commun. 2015 Sep 24;6:8451
pubmed: 26399326
Front Biol (Beijing). 2015 Jun;10(3):252-261
pubmed: 26557138
Eur J Immunol. 2016 May;46(5):1168-79
pubmed: 26910859
J Immunol. 2016 May 15;196(10):4052-63
pubmed: 27076678
Trends Immunol. 2016 Jun;37(6):351-353
pubmed: 27179621
Cell Rep. 2016 Jul 12;16(2):379-391
pubmed: 27373165
Curr Opin Immunol. 2016 Oct;42:105-112
pubmed: 27491008
J Immunol Methods. 2017 Jul;446:1-6
pubmed: 28365328
J Immunol. 2017 Jun 15;198(12):4753-4763
pubmed: 28526681
BMC Infect Dis. 2017 Sep 6;17(1):606
pubmed: 28874142
AIDS. 2017 Nov 13;31(17):2317-2330
pubmed: 28926399
Front Immunol. 2017 Sep 25;8:1189
pubmed: 28993778
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):221-229
pubmed: 29135655
Front Immunol. 2018 Feb 19;9:257
pubmed: 29520269
Front Immunol. 2018 Apr 09;9:486
pubmed: 29686665
PLoS Pathog. 2018 May 31;14(5):e1007104
pubmed: 29851983
Curr Opin HIV AIDS. 2018 Nov;13(6):512-521
pubmed: 30124473
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282828
PLoS One. 2019 Jun 6;14(6):e0217014
pubmed: 31170171
Clin Infect Dis. 2019 Jun 12;:null
pubmed: 31190065
J Exp Med. 1994 Sep 1;180(3):1171-6
pubmed: 8064234
J Exp Med. 1993 Jul 1;178(1):1-16
pubmed: 8391057